September 26, 2016 8:38 AM ET

Biotechnology

Company Overview of Liquidia Technologies, Inc.

Company Overview

Liquidia Technologies, Inc., a nanotechnology company, designs, develops, and manufactures precisely engineered particles and films for applications in life and materials science sectors. It develops micro and nanoparticles for the delivery of biological and small molecule therapeutics, as well as for the development of vaccines and inhaled therapeutics in the life sciences sector. The company also develops nano-patterned optical films for displays, lighting, photovoltaics, and related applications in the material science sector. Liquidia Technologies, Inc. was founded in 2004 and is based in Research Triangle Park, North Carolina.

419 Davis Drive

Suite 100

Morrisville, NC 27560

United States

Founded in 2004

Phone:

919-328-4400

Fax:

919-328-4402

Key Executives for Liquidia Technologies, Inc.

Chief Executive Officer and Director
Age: 54
Co-Founder and Senior Scientist
Co-Founder
Chief Financial Officer
Compensation as of Fiscal Year 2016.

Liquidia Technologies, Inc. Key Developments

Liquidia Technologies, Inc. Presents at Jefferies 2016 Healthcare Conference, Jun-09-2016 11:30 AM

Liquidia Technologies, Inc. Presents at Jefferies 2016 Healthcare Conference, Jun-09-2016 11:30 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Neal F. Fowler, Chief Executive Officer and Director.

Liquidia Technologies Appoints Mike A. Royal as Senior Vice President, Clinical Development

Liquidia Technologies announced that it has named Dr. Mike Royal to the position of Senior Vice President, Clinical Development with responsibility for the company's clinical research and development programs. Dr. Royal will report to Neal Fowler, Chief Executive Officer of Liquidia. Prior to Liquidia, Dr. Royal was Executive Vice President of Clinical and Regulatory Affairs at Sorrento Therapeutics where he focused on cancer therapeutics, targeted monoclonal antibodies and cellular therapies. Previously, he was Chief of Clinical Affairs at AcelRx Pharmaceuticals, where he was responsible for the Zalviso (a sufentanil sublingual microtablet system) New Drug Application (NDA). Before AcelRx, Dr. Royal was Vice President of Clinical Development and Medical Affairs for Cadence Pharmaceuticals where he designed and conducted the clinical development program for Ofirmev. Dr. Royal was also the Chief Medical Officer for Solstice Neurosciences where he was responsible for clinical and regulatory affairs for Myobloc. He was the Vice President of Strategic Brand Development at Alpharma Branded Products Division supporting Kadian. He was also the Vice President Global Medical Affairs at Alpharma, where he authored the clinical sections for nearly a dozen Abbreviated New Drug Applications (ANDA). Early in his career Dr. Royal was the founder, President and sole owner of the Pain Evaluation and Treatment Center.

Liquidia Technologies, Inc. Presents at BIO-Europe Spring 2016, Apr-05-2016 09:30 AM

Liquidia Technologies, Inc. Presents at BIO-Europe Spring 2016, Apr-05-2016 09:30 AM. Venue: Kistamässan Convention Center, Stockholm, Sweden.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Liquidia Technologies, Inc., please visit www.liquidia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.